Gestational trophoblastic disease

Elizabeth L. Dickson; Sally A Mullany

doi:10.1007/978-1-4939-1976-5_5

Gestational trophoblastic disease

Elizabeth L. Dickson, Sally A Mullany

Obstetrics, Gynecology and Women's Health - Oncology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

Gestational trophoblastic disease (GTD) is a term that encompasses a spectrum of disorders all arising from the placenta, and specifically, from the villous trophoblast of the placenta. These diseases include hydatidiform mole (both complete and partial), invasive mole, choriocarcinoma (CCA), and placental site trophoblastic tumor (PSTT). The term gestational trophoblastic neoplasia (GTN) includes the disorders of invasive mole, CCA, and PSTT, as they have significant clinical impact. While in the past, this spectrum of diseases was known to have serious morbidity and mortality, with current diagnosis and treatment, cure rates are quoted to upwards of 98 % (Sebire and Seckle, BMJ 227:A1193, 2008). In this chapter, diagnosis, staging, and management of gestational trophoblastic disease are discussed.

Original language	English (US)
Title of host publication	Gynecologic Oncology
Subtitle of host publication	A Pocketbook
Publisher	Springer New York
Pages	175-201
Number of pages	27
ISBN (Electronic)	9781493919765
ISBN (Print)	9781493919758
DOIs	https://doi.org/10.1007/978-1-4939-1976-5_5
State	Published - Jan 1 2015

Bibliographical note

Publisher Copyright:
© Springer Science+Business Media New York 2015.

Keywords

Choriocarcinoma
Hydatidiform mole
Invasive mole
Placental site trophoblastic tumor

Publisher link

10.1007/978-1-4939-1976-5_5

Find It

Find It at U of M Libraries

Cite this

@inbook{1e5a5cc4c5564be093a926b696a83a65,

title = "Gestational trophoblastic disease",

abstract = "Gestational trophoblastic disease (GTD) is a term that encompasses a spectrum of disorders all arising from the placenta, and specifically, from the villous trophoblast of the placenta. These diseases include hydatidiform mole (both complete and partial), invasive mole, choriocarcinoma (CCA), and placental site trophoblastic tumor (PSTT). The term gestational trophoblastic neoplasia (GTN) includes the disorders of invasive mole, CCA, and PSTT, as they have significant clinical impact. While in the past, this spectrum of diseases was known to have serious morbidity and mortality, with current diagnosis and treatment, cure rates are quoted to upwards of 98 % (Sebire and Seckle, BMJ 227:A1193, 2008). In this chapter, diagnosis, staging, and management of gestational trophoblastic disease are discussed.",

keywords = "Choriocarcinoma, Hydatidiform mole, Invasive mole, Placental site trophoblastic tumor",

author = "Dickson, {Elizabeth L.} and Mullany, {Sally A}",

note = "Publisher Copyright: {\textcopyright} Springer Science+Business Media New York 2015.",

year = "2015",

month = jan,

day = "1",

doi = "10.1007/978-1-4939-1976-5_5",

language = "English (US)",

isbn = "9781493919758",

pages = "175--201",

booktitle = "Gynecologic Oncology",

publisher = "Springer New York",

}

TY - CHAP

T1 - Gestational trophoblastic disease

AU - Dickson, Elizabeth L.

AU - Mullany, Sally A

N1 - Publisher Copyright: © Springer Science+Business Media New York 2015.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Gestational trophoblastic disease (GTD) is a term that encompasses a spectrum of disorders all arising from the placenta, and specifically, from the villous trophoblast of the placenta. These diseases include hydatidiform mole (both complete and partial), invasive mole, choriocarcinoma (CCA), and placental site trophoblastic tumor (PSTT). The term gestational trophoblastic neoplasia (GTN) includes the disorders of invasive mole, CCA, and PSTT, as they have significant clinical impact. While in the past, this spectrum of diseases was known to have serious morbidity and mortality, with current diagnosis and treatment, cure rates are quoted to upwards of 98 % (Sebire and Seckle, BMJ 227:A1193, 2008). In this chapter, diagnosis, staging, and management of gestational trophoblastic disease are discussed.

AB - Gestational trophoblastic disease (GTD) is a term that encompasses a spectrum of disorders all arising from the placenta, and specifically, from the villous trophoblast of the placenta. These diseases include hydatidiform mole (both complete and partial), invasive mole, choriocarcinoma (CCA), and placental site trophoblastic tumor (PSTT). The term gestational trophoblastic neoplasia (GTN) includes the disorders of invasive mole, CCA, and PSTT, as they have significant clinical impact. While in the past, this spectrum of diseases was known to have serious morbidity and mortality, with current diagnosis and treatment, cure rates are quoted to upwards of 98 % (Sebire and Seckle, BMJ 227:A1193, 2008). In this chapter, diagnosis, staging, and management of gestational trophoblastic disease are discussed.

KW - Choriocarcinoma

KW - Hydatidiform mole

KW - Invasive mole

KW - Placental site trophoblastic tumor

UR - http://www.scopus.com/inward/record.url?scp=84945125488&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84945125488&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1976-5_5

DO - 10.1007/978-1-4939-1976-5_5

M3 - Chapter

AN - SCOPUS:84945125488

SN - 9781493919758

SP - 175

EP - 201

BT - Gynecologic Oncology

PB - Springer New York

ER -

Gestational trophoblastic disease

Abstract

Bibliographical note

Keywords

Publisher link

Find It

Other files and links

Fingerprint

Cite this